Insider Trading & Ownership of SR ONE CAPITAL MANAGEMENT, LLC

Location
Wayne, PA
Summary
The estimated value of insider holdings of SR ONE CAPITAL MANAGEMENT, LLC is at least $129,221,980 dollars as of 14 Oct 2025. SR ONE CAPITAL MANAGEMENT, LLC is the 10%+ Owner of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $91.68M. SR ONE CAPITAL MANAGEMENT, LLC is the 10%+ Owner of Zenas BioPharma, Inc. and owns shares of Zenas BioPharma, Inc. (ZBIO) stock worth about $36.44M. SR ONE CAPITAL MANAGEMENT, LLC is the 10%+ Owner of eFFECTOR Therapeutics, Inc. and owns shares of eFFECTOR Therapeutics, Inc. (EFTR) stock worth about $1.1M.
Signature
/s/ Sasha Keough, attorney-in-fact for SR One Capital Management, LLC
All Insider Reports
All Insider Reports

Notify me when SR ONE CAPITAL MANAGEMENT, LLC files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of SR ONE CAPITAL MANAGEMENT, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ACLX Arcellx, Inc. 10%+ Owner $91,677,287 11 May 2023
ZBIO Zenas BioPharma, Inc. 10%+ Owner $36,440,005 +$2,399,985 +7.1% 09 Oct 2025
EFTR eFFECTOR Therapeutics, Inc. 10%+ Owner $1,104,688 27 Nov 2023

Insider Transactions Reported by SR ONE CAPITAL MANAGEMENT, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.